What is the difference between ALL and AML in children?

ALL (acute lymphoblastic leukaemia) affects lymphoid white blood cells and accounts for about 75–80% of childhood leukaemia cases. It responds very well to chemotherapy, with 85–90% complete remission at leading Indian centres. AML (acute myeloid leukaemia) affects myeloid cells and is less common but more aggressive — complete remission is achieved in 70–80% of cases, often requiring bone marrow transplant for long-term cure. CML (chronic myeloid leukaemia) is rare in children and is now effectively managed with targeted oral therapy (imatinib/dasatinib) rather than chemotherapy alone.

What are the childhood leukaemia survival rates at Indian hospitals?

At top Indian paediatric oncology centres such as Tata Memorial Mumbai and Apollo Delhi: ALL complete remission rate 85–90%, 5-year event-free survival 75–80% — comparable to outcomes in the USA and UK. AML complete remission 70–80%; 5-year survival rises to 50–60% with bone marrow transplant in high-risk cases. CML managed with targeted therapy has excellent long-term control. India publishes these outcomes in peer-reviewed journals; they reflect real-world results, not selected case series.

How much does childhood leukaemia treatment cost in India?

ALL chemotherapy (complete 2–2.5 year course) costs USD 8,000–18,000 in India. AML chemotherapy costs USD 15,000–30,000. If bone marrow transplant is required, expect USD 20,000–40,000 for an allogeneic (donor) transplant. These figures are 60–75% below USA costs of USD 200,000–500,000 for equivalent treatment. Costs include hospitalisation, drugs, blood products, and monitoring — Arodya provides itemised estimates before travel.

Can both parents stay with the child during treatment in India?

Yes. Indian hospitals actively encourage at least one parent to stay bedside, particularly during intensive induction chemotherapy. Most paediatric oncology wards have a parent cot or recliner in each room. Both parents are eligible for a Medical Attendant Visa (MX-Visa). For extended stays (2–3 months for induction and BMT), families typically rent a furnished apartment near the hospital at USD 25–60 per night. Arodya arranges accommodation before arrival.

How long does childhood leukaemia treatment take in India?

The intensive phase — induction chemotherapy — takes 4–8 weeks and requires continuous hospital presence in India. After achieving remission, consolidation chemotherapy cycles (2–4 weeks each) may be administered in India or back home with a local oncologist following the Indian team's written protocol. Total ALL treatment lasts 2–2.5 years, but most of the maintenance phase can be managed at home. If bone marrow transplant is needed, plan 8–12 weeks in India for conditioning, transplant, and engraftment monitoring.

Childhood Leukaemia Treatment India 2026

When your child is diagnosed with leukaemia, every day matters — and so does every dollar. For African families seeking the best possible care, childhood leukaemia treatment in India for African families in 2026 offers a combination that is hard to find anywhere else: world-class paediatric oncology protocols, 60–75% lower costs than the USA or UK, and hospitals that treat thousands of children with blood cancers every year. This guide explains what to expect, what it costs, and how to take the first step.

Types of Childhood Leukaemia Treated in India

Acute Lymphoblastic Leukaemia (ALL)

ALL is by far the most common childhood leukaemia, accounting for 75–80% of all cases. It develops when the bone marrow produces too many immature lymphoid white blood cells (lymphoblasts) that crowd out healthy blood cells. The good news is that ALL responds exceptionally well to chemotherapy — India's leading centres achieve complete remission in 85–90% of newly diagnosed children.

Acute Myeloid Leukaemia (AML)

AML affects myeloid cells and is less common but more aggressive than ALL. It requires more intensive chemotherapy, and many children with high-risk AML need a bone marrow transplant to achieve lasting remission. India's top centres achieve complete remission in 70–80% of children with AML, with 5-year survival rising to 50–60% when bone marrow transplant is performed.

Chronic Myeloid Leukaemia (CML)

CML is rare in children but, when it occurs, is now managed with targeted oral therapy — imatinib or dasatinib — rather than traditional chemotherapy. These drugs keep the disease under control with minimal side effects and are available at a fraction of Western costs in India. Some younger children with CML are cured permanently with bone marrow transplant.

Why Indian Hospitals Excel at Paediatric Leukaemia Care

India's leading oncology centres have built their paediatric leukaemia programmes on four pillars that matter most to families travelling from Africa.

Proven protocols. Indian hospitals follow the same internationally validated treatment protocols as Western centres — Children's Oncology Group (COG) and BFM protocols for ALL, and AML-BFM or COG protocols for AML. The drugs are identical; the regimens are identical. The difference is the cost of delivering them.

Volume and experience. Tata Memorial Hospital in Mumbai treats more than 2,000 new paediatric cancer cases every year. Apollo, AIIMS, and Rajiv Gandhi Cancer Institute collectively treat hundreds more. High volume means deeper experience with rare presentations, complications, and difficult cases.

Dedicated paediatric oncology units. Children are not treated on adult wards. India's top hospitals have dedicated paediatric haematology-oncology departments with child-friendly spaces, play therapy, schooling support, and staff trained specifically in child-centred care.

International patient infrastructure. English-speaking coordinators, visa assistance, accommodation guidance, and telemedicine follow-up for families who return home mid-treatment are all standard at JCI-accredited centres. Learn more about arranging paediatric cancer treatment through Arodya's intake process.

Treatment Protocols Used in India

Chemotherapy Phases for ALL

ALL chemotherapy follows a structured three-phase programme:

Induction (weeks 1–4): The most intensive phase. The goal is to eliminate as many leukaemia cells as possible and achieve complete remission. This phase requires continuous hospital stay in India. Drugs typically include vincristine, asparaginase, dexamethasone, and intrathecal (spinal) methotrexate to protect the central nervous system.

Consolidation (months 2–8): Maintains and deepens remission through alternating courses of chemotherapy. Some cycles can be administered at home by a local oncologist following the Indian team's written protocol — making it possible for families to return to Africa between visits.

Maintenance (months 9–30): Daily oral 6-mercaptopurine, weekly methotrexate, and monthly vincristine/steroid pulses. This phase is almost entirely outpatient and can be managed locally. The Indian team provides the complete protocol in writing.

Treatment for AML

AML induction typically uses cytarabine and anthracyclines (daunorubicin or idarubicin) over 4–8 weeks of intensive hospitalisation. Consolidation follows with additional intensive cycles. High-risk AML — defined by specific genetic markers or failure to achieve remission quickly — proceeds to bone marrow transplant from a sibling or matched unrelated donor.

When Bone Marrow Transplant Is Needed

BMT is recommended for: AML (high-risk or relapsed), ALL that relapses after initial remission, and ALL with very high-risk genetic features (Philadelphia chromosome-positive ALL). India's BMT centres perform both allogeneic (donor) and autologous (own cells) transplants, with sibling donors preferred for best outcomes.

Childhood Leukaemia Treatment Cost in India

India offers the same chemotherapy drugs and treatment protocols as the USA and UK at a fraction of the cost. The savings are structural — lower hospital overheads, lower professional fees, and government pricing controls on essential cancer drugs.

Treatment	India	USA	Savings
ALL chemotherapy — complete 2–2.5 year course	USD 8,000–18,000	USD 200,000–400,000	~95%
AML chemotherapy — full intensive course	USD 15,000–30,000	USD 250,000–500,000	~94%
Bone marrow transplant (allogeneic, sibling donor)	USD 20,000–40,000	USD 300,000–500,000	~92%

What these costs include: hospitalisation, all chemotherapy drugs and blood products, bone marrow aspirates and biopsies, MRI/CT/PET imaging, and physician fees. Flights, accommodation, and visa fees are additional.

Cost planning tip: For ALL, the highest costs fall in the first 4–8 weeks of induction (in India). Consolidation and maintenance costs drop significantly and can be partially or fully administered at home, making the total cost manageable over time. Arodya provides a phased payment schedule from the hospital before any commitment is made.

Survival Rates and Outcomes at Indian Hospitals

India's best paediatric oncology centres publish outcomes that are directly comparable to Western institutions:

ALL in children: 85–90% complete remission after induction; 75–80% event-free survival at 5 years
AML in children: 70–80% complete remission; 50–60% 5-year survival with BMT
CML: Excellent long-term disease control with targeted therapy; curative rates with BMT in younger children
ALL relapse: India's centres offer salvage chemotherapy and second-line protocols for children who relapse, including CAR-T therapy at select centres

These figures come from peer-reviewed publications by Tata Memorial, Apollo, CMC Vellore, and AIIMS — not marketing materials. They reflect real-world results across thousands of children, including many who arrived with advanced or previously treated disease.

Top Hospitals for Paediatric Leukaemia

Tata Memorial Hospital, Mumbai

India's premier cancer institution, run by the Government of India. Tata Memorial treats over 2,000 new paediatric cancer cases annually and has the country's most experienced paediatric leukaemia team. Its BMT unit performs more than 400 transplants per year. Lower cost than private hospitals, with outcomes that match or exceed private sector results.

Apollo Cancer Centres, Delhi and Chennai

JCI-accredited. Apollo's paediatric oncology programme has dedicated consultants, child-friendly wards, and comprehensive international patient services. Strong BMT programme with a dedicated isolation unit. English-speaking coordinators available from the first inquiry.

AIIMS Delhi

The premier public academic medical institution in India. AIIMS Delhi's paediatric haematology-oncology department handles complex and refractory cases and trains India's next generation of oncologists. Longer waiting times than private hospitals, but among the lowest costs in India.

Rajiv Gandhi Cancer Institute (RGCI), Delhi

A dedicated cancer hospital with a well-established paediatric oncology unit. Strong BMT programme and good international patient infrastructure. Convenient for families preferring to be based in India's capital.

Narayana Health, Bangalore

Part of Narayana's nationwide network, with dedicated paediatric oncology services. Narayana combines affordable pricing with quality care and is particularly accessible for families from East Africa due to Bangalore's direct flight connections with Nairobi and Addis Ababa.

Support for Families: Accommodation, Translators, Emotional Support

Travelling to India with a sick child is an enormous undertaking. India's top hospitals — and Arodya — provide structured support to make it manageable.

Accommodation. Most families rent furnished service apartments within walking distance of the hospital for induction chemotherapy (4–8 weeks). Cost ranges from USD 25–60 per night. Some hospitals have on-campus family accommodation wings. Arodya books accommodation before arrival so families step off the plane with a confirmed address.

Translation and language support. India's top hospitals operate primarily in English, and most senior oncologists speak excellent English. For families more comfortable in French (common across West and Central Africa), Arodya provides French-speaking coordinators.

Financial guidance. Arodya provides itemised cost estimates from the hospital — broken into phases — before any travel is booked. There are no hidden costs or surprise billing. Families know what each phase will cost before they commit.

Emotional and psychosocial support. India's leading paediatric oncology centres employ child psychologists, play therapists, and social workers as part of the team. Parents are supported as well — most centres have family counselling available. Arodya's coordinators are reachable at all hours during treatment.

Continuation of care at home. When families return to Africa between treatment phases, Arodya connects them with paediatric oncologists in their home country to administer maintenance chemotherapy. The Indian hospital provides written protocols in standard international format.

Step-by-Step: How to Arrange Treatment in India

Step 1 — Gather records. Collect all available medical records: biopsy or bone marrow biopsy reports, blood counts (FBC with differential), bone marrow aspirate and trephine results, any imaging (CT, MRI, PET-CT), and details of any treatment already received. If pathology slides are available, request physical slides rather than just reports — Indian teams often review slides directly.

Step 2 — Submit your case. Send records through Arodya's intake form. Arodya reviews the case and, where needed, routes it to the right specialist team at the most appropriate hospital for the diagnosis and budget.

Step 3 — Receive a treatment plan and cost estimate. Within 3–5 days, the paediatric oncology team provides a written treatment plan and itemised cost estimate covering each phase of treatment. This is provided before any commitment to travel.

Step 4 — Apply for medical visas. The patient receives a Medical Visa (M-Visa); both parents are eligible for Medical Attendant Visas (MX-Visas). Arodya provides the hospital appointment letter required for the application. Processing takes 3–7 days in most African capitals; urgent cases can be expedited to 24–48 hours.

Step 5 — Travel and begin treatment. Arodya arranges airport pickup and hospital registration. The first consultation with the paediatric oncologist typically happens within 24 hours of arrival. Chemotherapy for ALL often begins within 48–72 hours of confirmed diagnosis.

Step 6 — Manage the treatment journey. Arodya's on-ground coordinator stays in contact throughout the induction phase — helping with accommodation, daily hospital logistics, medication queries, and communication with the medical team.

Step 7 — Return home between phases. Once induction is complete and the child is stable, families can return home. Arodya connects you with a paediatric oncologist in your home country to continue consolidation or maintenance chemotherapy following the Indian team's protocol.

Step 8 — Plan return visits. Families return to India for bone marrow assessments, end-of-treatment evaluations, and any treatment intensification decisions. Arodya coordinates these return visits to minimise disruption and cost.

Your child's leukaemia diagnosis does not have to define their future. Thousands of children from across Africa have received treatment in India and returned home in remission. The medical expertise is real, the costs are transparent, and the support infrastructure is in place. Start your case today — Arodya's team will respond within 24 hours.

Childhood Leukaemia Treatment in India for African Families: Guide 2026